Jonathan Wrathall, PhD, explains that his 2 studies found social needs and insurance type strongly predicted food insecurity.

Of the 3 primary breast cancer subtypes (estrogen receptor [ER]–positive, HER2-positive, and triple negative), the recent ...

Epidemiology links AA and atopy: up to 40% of AA patients have atopic comorbidities, and concurrent AD predicts poorer response and relapse. Immune profiling shows mixed Th1/Th2/Th22 activation with ...

Improved BTK selectivity with zanubrutinib is associated with fewer off-target toxicities that commonly limit ibrutinib, where AE-driven discontinuation reached 16%–28% in trials and higher real-world ...

Cost advantages concentrated in higher OOP tiers: only 15% of all prescriptions were cheaper, but MCCPDC undercut insurance for ~82% of fills when OOP exceeded $15. Therapeutic areas with frequent ...

Identification of fibroids on ultrasound can prematurely close evaluation, despite frequent co-existence and a ...

Swarup Kumar, MD, discusses how bispecific antibodies are pushing myeloma cure rates to 40%—and what clinicians must know ...

The heart failure (HF) treatment landscape continues to evolve rapidly in 2026, with emerging evidence pointing toward a ...

Retatrutide met primary and key secondary endpoints in a 2339-participant, randomized, double-blind, placebo-controlled phase 3 trial, demonstrating clinically meaningful weight reduction across 4, 9, ...

Young men and minority patients with early-onset CRC in urban areas face higher CVD death risk, challenging assumptions about ...

Datopotamab deruxtecan is now a first-line targeted therapy for immunotherapy-ineligible metastatic TNBC, addressing the ~70% ...

Simple FNI labs pinpoint high‑mortality MASLD fibrosis in type 2 diabetes, challenging FIB‑4 and sharpening MASH liver ...